Characteristics | All Patients n = 152 | Dead = 58 | Alive = 94 | P value |
---|---|---|---|---|
Age in years, median (de) | 42 (9.91) | 45.5 (9.44) | 40 (9.97) | 0.007* |
Male, n (%) | 108 (71.05%) | 45 (77.59%) | 63 (67.02%) | 0.163 |
Weight Kg, median (de) | 85.5 (17.08 | 86.1 (16.59) | 85.2 (17.47) | 0.761 |
Body mass index, kg/cm2 median (de) | 29.7 (5.15) | 29.8 (5.22) | 29.6 (5.13) | 0.817 |
Days in ICU - M (RIC) | 24.1 (13.4–39.9) | 14.4 (6.8–26.7) | 30.5 (18.8–48.2) | < 0,001* |
Days in mechanical ventilation | 17.4 (10.5–26.7) | 15.4 (8.77–23.3) | 19 (12.9–27.2) | 0.669 |
Days hospitalized | 29(16–51) | 17 (8–29) | 39 (25–57) | 0,005* |
Comorbilities, n (%) | ||||
Arterial hypertension | 28 (18.4%) | 13 (22.4%) | 15(15.9%) | 0.319 |
Diabetes | 22 (14.4%) | 7 (12.1%) | 15 (15.9%) | 0.508 |
Dislypidemia | 6 (3.9%) | 2 (3.4%) | 4 (4.2%) | 0.804 |
Asthma | 8 (5.2%) | 4(6.9%) | 4 (4.2%) | 0.479 |
Active smoker | 7 (4.6%) | 3 (5.1%) | 4 (2%) | 0.793 |
Laboratories previous to cannulation, median (ds) | ||||
Potassium meq/l | 4.01 (0.96) | 3.78 (1.27) | 4.15(0.66) | 0.044* |
Creatinine mg/dl | 1.60(3.82) | 1.54 (1.16) | 1.64 (4.78) | 0.847 |
Ureic nitrogen | 27.8 (18.9) | 30.8 (19.61) | 26 (18.3) | 0.134 |
Infection, n (%) | ||||
SARS-CoV-2 | 117(76.9%) | 48(82.7) | 69(73.4%) | 0.183 |
Mode of Support (%) | 0.881 | |||
Venovenous ECMO | 115(75.6%) | 44 (75.8%) | 71 (75.5%) | |
Venoarterial ECMO | 33 (21.7%) | 13 (22.4%) | 20 (21.2%) | |
Venoarteriovenous ECMO | 4 (2.7%) | 1 (1.72%) | 3 (3.19%) | |
Membranes, n (%) | 0.118 | |||
Sorin | 73(48%) | 22(37.9%) | 51(54.2%) | |
Euroset | 47(30.9%) | 20(34.4%) | 27(28.7%) | |
Polypropilane-Inspire | 32 (21%) | 16(27,5%) | 16(17%) | |
Severity score M (RIC) | ||||
SOFA Score | 7(5–9) | 8(6–11) | 7(4–9) | 0,101 |
APACHE II Score | 9(5.5–14) | 11 (6–17) | 8 (5–12) | < 0,001* |
Oxygen debt DEOx | “- 1.16((−13.2) -10.8) | 5.01 ((−9.8)-12.8) | “-4.44((−15.2)-6.67) | < 0,001* |
RESP | 3(2–4) | 2(1–4) | 4(2–5) | 0.255 |
SAVE | 0(−3 a 0) | 0 (−2 a 1) | “-5 (−3–0) | 0.494 |
Complications, n (%) | ||||
Mechanical | 34 (22.3%) | 13(22.4%) | 21(22.3%) | 0.647 |
Mayor bleeding | 20 (13.1%) | 10(17.2%) | 10(10.6%) | 0.242 |
Neurological | 27(17.7%) | 20(34.4%) | 7(7.4%) | < 0,001* |
Cardiovascular | 18(11.8%) | 11(18.9%) | 7(7.4%) | 0.033* |
Renal | 39(25.6%) | 21(36.2%) | 18(19.1%) | 0.019* |
Infection | 115(75%) | 29(67.7%) | 76(80.8%) | 0.05* |
Oxigenator failure | 22(14.4%) | 8(13.7%) | 14(14.8%) | 0.85 |
Delirium | 83(54.6%) | 13(2.4%) | 70(74.4%) | < 0,001* |
Renal replacement therapy | 62(40.7%) | 24(41.3%) | 38(40.4%) | 0.97 |